Quick Answer
IMMUCELL CORP /DE/ reported Earnings Per Share Diluted of $0.12 (loss) per share for the year ending 2025.
- IMMUCELL CORP /DE/ showed an increase of +53.8% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from IMMUCELL CORP /DE/'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), IMMUCELL CORP /DE/'s Earnings Per Share Diluted has declined by 71.4%.
- Historical annual values: Fiscal year 2025: $0.12 (loss) per share | Fiscal year 2024: $0.26 (loss) per share | Fiscal year 2023: $0.75 (loss) per share | Fiscal year 2022: $0.32 (loss) per share | Fiscal year 2021: $0.01 (loss) per share | Fiscal year 2020: $0.14 (loss) per share | Fiscal year 2019: $0.19 (loss) per share | Fiscal year 2018: $0.42 (loss) per share | Fiscal year 2017: $0.03 (loss) per share | Fiscal year 2016: $0.12 per share | Fiscal year 2015: $0.38 per share | Fiscal year 2014: $0.06 (loss) per share | Fiscal year 2013: $0.04 per share | Fiscal year 2012: $0.03 per share | Fiscal year 2011: $0.14 (loss) per share | Fiscal year 2010: $0.13 (loss) per share | Fiscal year 2009: $0.07 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: